Xolair differs from other antiasthmatics and is indicated in treatment of exactly allergic asthma. It is not used in children younger than 12. It reduces hypersensitivity in allergic persons and that way reduces number of attacks. Xolair is monoclonal therapeutic
antibody that binds to
IgE and blocks it. It is approved by fda 3 years ago, for treatment of moderate to severe asthma in patients that had positive allergy test on perennial aeroallergen. It is administered as injection. Xolair is used along with corticosteroids and decreases number and severity of asthma attacks. Hope that helped.
Did you find this post useful?

5

5